You are using an outdated browser. Please upgrade your browser to improve your experience.

Tchem
BRSK2
Serine/threonine-protein kinase BRSK2

Protein Summary
Description
Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion (PubMed:22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion (PubMed:22669945) ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000308219
  • ENSP00000310697
  • ENSG00000174672
  • ENST00000382179
  • ENSP00000371614
  • ENST00000526678
  • ENSP00000433370
  • ENST00000528710
  • ENSP00000433235
  • ENST00000528841
  • ENSP00000432000
  • ENST00000529433
  • ENSP00000433684
  • ENST00000531197
  • ENSP00000431152

Symbol
  • C11orf7
  • PEN11B
  • SADA
  • STK29
  • SAD1
  • SADA
  • STK29
  • PEN11B
  • C11orf7
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
molecular function
0.98
protein domain
0.73
tissue sample
0.71
transcription factor
0.71
biological process
0.7


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 103.57   (req: < 5)
Gene RIFs: 13   (req: <= 3)
Antibodies: 206   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 103.57   (req: >= 5)
Gene RIFs: 13   (req: > 3)
Antibodies: 206   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 26
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 3
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0